Quantifying beta-agonist utilization: Occasions or puffs?

The Global Initiative for Asthma and the National Asthma Education and Prevention Program (NAEPP) both recommend assessing the frequency and number of inhalations of short-acting beta-agonists (SABAs) in asthma as important measures of asthma control and severity.1,2 Some ambiguity exists, though, a...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	The journal of allergy and clinical immunology in practice (Cambridge, MA) MA), 2019-03, Vol.7 (3), p.1088-1090
Hauptverfasser:	Szefler, Stanley J., Hoch, Heather E., Tuffli, Michael, Gondalia, Rahul, Barrett, Meredith A., Van Sickle, David, Stempel, David A.
Format:	Artikel
Sprache:	eng
Schlagworte:	Asthma Clinical decision making Clinical trials Decision making Patients Sensors Task forces Thorax
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!